Clinical Trials Logo

Clinical Trial Summary

The primary objective of the study was to compare the efficacy of Octaplas LG with Octaplas SD in terms of recovery of coagulation factors and other haemostatic parameters. The secondary objective of the study was to compare the safety and tolerability of Octaplas LG with Octaplas SD in terms of haematological and clinical chemistry parameters and adverse event monitoring.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms

  • Comparison of Octaplas LG and Octaplas SD

NCT number NCT01063595
Study type Interventional
Source Octapharma
Contact
Status Completed
Phase Phase 1
Start date December 2009
Completion date July 2010